Preferred Label : Limb-girdle muscular dystrophy 2O, POMGNT1 gene mutation;
ICD-11 definition : Limb-girdle muscular dystrophy-dystroglycanopathy (type C3; MDDGC3), also known as
LGMD2O, is caused by homozygous mutation in the gene encoding protein O-mannose beta-1,2-N-acetylglucosaminyltransferase
(POMGNT1) on chromosome 1p34. It is a rare form of autosomal recessive limb-girdle
muscular dystrophy with normal cognition, and it is part of a group of similar disorders
resulting from defective glycosylation of alpha-dystroglycan collectively known as
dystroglycanopathies.;
ICD-11 synonym : limb-girdle muscular dystrophy 2O; LGMD2O - [limb-girdle muscular dystrophy 2O]; MDDGC3; Limb-girdle muscular dystrophy-dystroglycanopathy (type C3); Limb-girdle muscular dystrophy-dystroglycanopathy;
ICD-11 acronym : LGMD2O;
Origin ID : 1006273551;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
Limb-girdle muscular dystrophy-dystroglycanopathy (type C3; MDDGC3), also known as
LGMD2O, is caused by homozygous mutation in the gene encoding protein O-mannose beta-1,2-N-acetylglucosaminyltransferase
(POMGNT1) on chromosome 1p34. It is a rare form of autosomal recessive limb-girdle
muscular dystrophy with normal cognition, and it is part of a group of similar disorders
resulting from defective glycosylation of alpha-dystroglycan collectively known as
dystroglycanopathies.